Skip to main content

GOLDMAN SACHS GROUP INC

Position in ABEO — Abeona Therapeutics Inc.

CIK 886982 NEW YORK, NY

Position in ABEO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$5,065,173
+$2,418,664 QoQ
Shares Held
1,130,619
+125.1% QoQ
Ownership
1.98%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. ABEO ranks #179 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ABEO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,065,173 1,130,619
2025-12-31 $2,646,509 502,184
2025-09-30 $1,702,435 322,431
2025-06-30 $778,989 137,146
2025-03-31 $954,142 200,450
2024-12-31 $746,535 134,028
2024-03-31 $1,243,614 171,533
2023-06-30 $859,526 213,282
2023-03-31 $460,432 163,274
2022-12-31 $522,555 169,661